Chimerix (NASDAQ:CMRX) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Chimerix (NASDAQ:CMRX – Free Report) in a report issued on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other brokerages have also commented on CMRX. Wedbush reissued a “neutral” rating and issued a $8.55 price objective (up previously from $7.00) on […]
StockNews.com began coverage on shares of Chimerix (NASDAQ:CMRX – Free Report) in a report issued on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other brokerages have also commented on CMRX. Wedbush reissued a “neutral” rating and issued a $8.55 price objective (up previously from $7.00) on […]
